Juleen R. Zierath

@juleenrzierath.bsky.social

Professor of Physiology at Karolinska Institutet - SRP Diabetes & University of Copenhagen - Center for Basic Metabolic Research. Lifelong Athlete. Member of Nobel Assembly, Royal Swedish Academy of Sciences, Keystone Symposia Board, & Past President EASD.

Exercise timing and circadian regulation of metabolism in type 2 diabetes. Our latest review: Exercise modulates our biological rhythms, with timing emerging as an important factor for metabolic outcomes in type 2 diabetes. www.sciencedirect.com/science/arti...

Exercise timing and circadian regulation of metabolism in type 2 diabetes

The circadian system regulates daily rhythms in metabolism and hormone secretion; however, in type 2 diabetes, disrupted clock gene oscillations in sk…

sciencedirect.com

The Zierath/Krook/Wallberg lab celebrated our current & former fellows & students at Nobel Forum with a fantastic symposium on insulin action & metabolism. Grateful for all who traveled far & near to be with us to focus on science, inclusion, and innovation! photographer: Stefan Zimmerman

Bild

The Zierath/Krook/Wallberg lab celebrated our current & former fellows and students at Nobel Forum sept 1 with a fantastic symposium on insulin action & metabolism. Grateful for all the trainees who traveled far & near to be with us to focus on science, inclusion, and innovation!

Bild

Obesity is a global public health concern closely linked to cardiometabolic complications. This Comment provides views on recent breakthroughs, emerging innovations and future needs of therapeutic interventions to counteract obesity and its associated health risks. www.nature.com/articles/s42...

Shaping the future of cardiometabolic innovation: advances and opportunities - Nature Metabolism

Obesity is a global public health concern closely linked to cardiometabolic complications. This Comment provides our views on recent breakthroughs, emerging innovations and future needs of therapeutic...

nature.com

Our latest! Great collaborative effort with David Rizo-Roca & John Henderson! Metabolomics in cardiometabolic diseases: Key biomarkers and therapeutic implications for insulin resistance and diabetes - Journal of Internal Medicine - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/...

<em>Journal of Internal Medicine</em> | Wiley Online Library

Cardiometabolic diseases—including Type 2 diabetes and obesity—remain leading causes of global mortality. Recent advancements in metabolomics have facilitated the identification of metabolites that a...

onlinelibrary.wiley.com